Sustained Remission After Combination Therapy with Rituximab and Etanercept in Two Patients with Rheumatoid Arthritis After TNF Failure: Case Report

OBJECTIVES: Approximately up to 40% of patients with rheumatoid arthritis (RA) fail to respond to tumor necrosis factor (TNF) inhibitors, lose response over time or are unable to tolerate treatment. MATERIALS AND METHODOLOGY: We report two female patients suffering from active, refractory rheumatoid...

Descripción completa

Detalles Bibliográficos
Autores principales: Feuchtenberger, Martin, Kneitz, Christian, Roll, Petra, Kleinert, Stefan, Tony, Hans-Peter
Formato: Texto
Lenguaje:English
Publicado: Bentham Open 2009
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2684711/
https://www.ncbi.nlm.nih.gov/pubmed/19479056
http://dx.doi.org/10.2174/1874312900903010009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2684711/
https://www.ncbi.nlm.nih.gov/pubmed/19479056
http://dx.doi.org/10.2174/1874312900903010009

Ejemplares similares